NanoViricides, Inc. (NNVC) Sees Significant Decline in Short Interest
NanoViricides, Inc. (NYSEAMERICAN:NNVC) was the target of a large drop in short interest during the month of November. As of November 30th, there was short interest totalling 1,026,735 shares, a drop of 28.3% from the November 15th total of 1,431,399 shares. Based on an average daily volume of 131,481 shares, the short-interest ratio is presently 7.8 days. Currently, 1.9% of the shares of the company are short sold.
Shares of NanoViricides (NYSEAMERICAN NNVC) opened at $1.04 on Tuesday. NanoViricides has a fifty-two week low of $0.91 and a fifty-two week high of $1.64.
NanoViricides (NYSEAMERICAN:NNVC) last released its quarterly earnings results on Tuesday, November 14th. The company reported ($0.03) earnings per share for the quarter.
COPYRIGHT VIOLATION WARNING: This article was first posted by American Banking News and is owned by of American Banking News. If you are accessing this article on another publication, it was illegally stolen and reposted in violation of U.S. and international trademark and copyright laws. The correct version of this article can be viewed at https://www.americanbankingnews.com/2017/12/12/nanoviricides-inc-nnvc-sees-significant-decline-in-short-interest.html.
NanoViricides Company Profile
NanoViricides, Inc is a nano-biopharmaceutical company. The Company is a development-stage company with several drugs in various stages of development. The Company focuses on its research and clinical programs on specific anti-viral therapeutics. The Company is engaged in the application of nanomedicine technologies to the issues of viral diseases.
Receive News & Ratings for NanoViricides Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for NanoViricides Inc. and related companies with MarketBeat.com's FREE daily email newsletter.